| Ytd | -53.42% | |
| 1y | -96.85% |
| Open | 1.97 | Prev Close | 1.98 | Low | 1.81 | High | 2.02 | Mkt Cap | 139.89M |
| Vol | 41.21K | Avg Vol | 45.65K | EPS | -0.06 | P/E | N/A | Forward P/E | N/A |
| Beta | 2.38 | Short Ratio | 0.56 | Inst. Own | 0.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 2.12 | 200-d Avg | 2.26 | 1yr Est | 0.00 |
Jyong Biotech Ltd. (NASDAQ:MENS) (the "Company" or "Jyong Biotech"), a science-drive
New Taipei City, Taiwan, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "C